Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS)

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2023-04, Vol.178, p.S85-S86
Main Authors: Fennell, Dean, Griffiths, Daniel, Eminton, Zina, Morgan-Fox, Abigail, Hill, Kayleigh, Nearchou, Theodora, Johnson, Lucy, Harding, Stephanie, Poile, Charlotte, Bzura, Aleksandra, Spicer, Jake, Nye, Mavis, Cave, Judith, Danson, Sarah, Toy, Elizabeth, Jain, Pooja, Steele, Nicola, Shaw, Paul, Taylor, Paul, Szlosarek, Peter, Papadatos-Pastos, Dionysis, Lind, Michael, Dulloo, Sean, Saman, Harman, Bajaj, Amrita, Luo, Jin-Li, Darlison, Liz, Griffiths, Gareth
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0169-5002
DOI:10.1016/S0169-5002(23)00620-7